Assessment of influence of the long-term treatment with inhaled glucocorticoid on growth and body weight in asthmatic children aged 6 to 24 month
<p><strong>Background:</strong> Inhaled glucocorticoids are drugs of the first choice for the asthma treatment. Their growth suppressive potential is well known. It has been suggested that it may wane off during the first year of treatment. It has been also suspected that asthmatic...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Slovenian Medical Association
2005-05-01
|
| Series: | Zdravniški Vestnik |
| Subjects: | |
| Online Access: | http://vestnik.szd.si/index.php/ZdravVest/article/view/2110 |
| _version_ | 1818040599639490560 |
|---|---|
| author | Lilijana Besednjak-Kocijančič |
| author_facet | Lilijana Besednjak-Kocijančič |
| author_sort | Lilijana Besednjak-Kocijančič |
| collection | DOAJ |
| description | <p><strong>Background:</strong> Inhaled glucocorticoids are drugs of the first choice for the asthma treatment. Their growth suppressive potential is well known. It has been suggested that it may wane off during the first year of treatment. It has been also suspected that asthmatic children might become overweight/obese after asthma therapy. The aim of this prospective study was to assess the influence of long-term treatment with fluticasone propionate (FP) on body weight and growth in asthmatic children aged 6 to 24 month.</p><p><strong>Methods:</strong> 26 pairs of children of the same age with birth weight > 3000 g took part in 12-month parallel group trial. Group A consisted of children with mild persistent asthma treated for the first time. Inhaled FP 100 µg twice daily was used. Group B consisted of healthy children. In each group there were 17 males and 9 females. Weight and height data during 6-month prior to enrolment in the trial were retrospectively collected from the notes. Length and weight of both children from a pair were measured on the same day from day 1 every 3 month up to a year on the same measuring instrument. SPSS software 10.0 was used for statistical analyses. t-tests were employed for between-group analyses.</p><p><strong>Results:</strong> Mean weight was greater for 156 g in group A (t = 0.29, p = 0.77, DF: 24), and the mean length increase was greater for 0.72 cm in group B (t = –1.06, p = 0.30, DF: 24). The differences between group A and B were not statistically significant. A marked decrease in mean length difference from 0.26 in the first to 0.09 cm in the last quarter of the study was observed.</p><p><strong>Conclusions:</strong> Long-term treatment with inhaled glucocorticoids (100 µg FP twice daily) is safe in spite to their suppressive effect on growth. The growth suppressive potential of inhaled glucocorticoids is decreasing during the treatment. There is a no significant influence on body weight.</p> |
| first_indexed | 2024-12-10T08:17:06Z |
| format | Article |
| id | doaj.art-45e8142a0e8747db9380911ffdaf4d01 |
| institution | Directory Open Access Journal |
| issn | 1318-0347 1581-0224 |
| language | English |
| last_indexed | 2024-12-10T08:17:06Z |
| publishDate | 2005-05-01 |
| publisher | Slovenian Medical Association |
| record_format | Article |
| series | Zdravniški Vestnik |
| spelling | doaj.art-45e8142a0e8747db9380911ffdaf4d012022-12-22T01:56:26ZengSlovenian Medical AssociationZdravniški Vestnik1318-03471581-02242005-05-017451606Assessment of influence of the long-term treatment with inhaled glucocorticoid on growth and body weight in asthmatic children aged 6 to 24 monthLilijana Besednjak-Kocijančič<p><strong>Background:</strong> Inhaled glucocorticoids are drugs of the first choice for the asthma treatment. Their growth suppressive potential is well known. It has been suggested that it may wane off during the first year of treatment. It has been also suspected that asthmatic children might become overweight/obese after asthma therapy. The aim of this prospective study was to assess the influence of long-term treatment with fluticasone propionate (FP) on body weight and growth in asthmatic children aged 6 to 24 month.</p><p><strong>Methods:</strong> 26 pairs of children of the same age with birth weight > 3000 g took part in 12-month parallel group trial. Group A consisted of children with mild persistent asthma treated for the first time. Inhaled FP 100 µg twice daily was used. Group B consisted of healthy children. In each group there were 17 males and 9 females. Weight and height data during 6-month prior to enrolment in the trial were retrospectively collected from the notes. Length and weight of both children from a pair were measured on the same day from day 1 every 3 month up to a year on the same measuring instrument. SPSS software 10.0 was used for statistical analyses. t-tests were employed for between-group analyses.</p><p><strong>Results:</strong> Mean weight was greater for 156 g in group A (t = 0.29, p = 0.77, DF: 24), and the mean length increase was greater for 0.72 cm in group B (t = –1.06, p = 0.30, DF: 24). The differences between group A and B were not statistically significant. A marked decrease in mean length difference from 0.26 in the first to 0.09 cm in the last quarter of the study was observed.</p><p><strong>Conclusions:</strong> Long-term treatment with inhaled glucocorticoids (100 µg FP twice daily) is safe in spite to their suppressive effect on growth. The growth suppressive potential of inhaled glucocorticoids is decreasing during the treatment. There is a no significant influence on body weight.</p>http://vestnik.szd.si/index.php/ZdravVest/article/view/2110inhaled glucocorticoidasthmagrowthchild |
| spellingShingle | Lilijana Besednjak-Kocijančič Assessment of influence of the long-term treatment with inhaled glucocorticoid on growth and body weight in asthmatic children aged 6 to 24 month Zdravniški Vestnik inhaled glucocorticoid asthma growth child |
| title | Assessment of influence of the long-term treatment with inhaled glucocorticoid on growth and body weight in asthmatic children aged 6 to 24 month |
| title_full | Assessment of influence of the long-term treatment with inhaled glucocorticoid on growth and body weight in asthmatic children aged 6 to 24 month |
| title_fullStr | Assessment of influence of the long-term treatment with inhaled glucocorticoid on growth and body weight in asthmatic children aged 6 to 24 month |
| title_full_unstemmed | Assessment of influence of the long-term treatment with inhaled glucocorticoid on growth and body weight in asthmatic children aged 6 to 24 month |
| title_short | Assessment of influence of the long-term treatment with inhaled glucocorticoid on growth and body weight in asthmatic children aged 6 to 24 month |
| title_sort | assessment of influence of the long term treatment with inhaled glucocorticoid on growth and body weight in asthmatic children aged 6 to 24 month |
| topic | inhaled glucocorticoid asthma growth child |
| url | http://vestnik.szd.si/index.php/ZdravVest/article/view/2110 |
| work_keys_str_mv | AT lilijanabesednjakkocijancic assessmentofinfluenceofthelongtermtreatmentwithinhaledglucocorticoidongrowthandbodyweightinasthmaticchildrenaged6to24month |